Temperatures Rising: Patients Taking Diuretics May See More Benefit by Upping Potassium Intake During Warmer Weather

Temperatures Rising: Patients Taking Diuretics May See More Benefit by Upping Potassium Intake During Warmer Weather

Newswise — PHILADELPHIA – Patients taking diuretics are often at risk for low potassium levels, which can put patients at an increased risk of death from cardiac arrhythmias or other causes. But researchers from the Perelman School of Medicine at the University of Pennsylvania found that taking prescription potassium supplements can reduce these patients’ risk by nearly 10 percent as daily outdoor temperatures increase—a time when patients may be at highest risk due to loss of potassium while sweating. These findings are detailed in a study published today in BMJ Open. The drug furosemide, a diuretic known commonly as Lasix, is prescribed to patients with heart failure, high blood pressure, and/or kidney and liver disease, to decrease fluid retention and combat swelling in the arms, legs, and/or abdomen. The drug, like many other diuretics, causes patients to urinate more than normal, leading to lower levels of potassium in the body. These lower levels can be more dangerous when outdoor temperatures are high, as patients often lose additional potassium through sweating.  

“We already know that hot outdoor temperatures are associated with increased risk of heat stroke, dehydration, heart disease, respiratory diseases, and higher risk of death overall, but people who take furosemide and have insufficient intake of potassium are at increased risk,” said senior author Sean Hennessy, PharmD, PhD, a professor of Epidemiology and Systems Pharmacology and Translational Therapeutics. “As outside temperatures increase, the apparent survival benefit of potassium also increases.” The study looked at 1999-2010 data from United States Medicaid patients in California, Florida, New York, Ohio, and Pennsylvania – about 40 percent of total U.S. Medicaid enrollees – making up approximately 20 percent of the total U.S. population. Data was included from those who took furosemide, 40 mg/day or higher and had not been prescribed any furosemide nor diagnosed of hypokalemia – insufficient potassium in the blood— in the previous 365 days.

Among the 337,885 people who took 40 mg/day or more of furosemide, 32 percent of them also took potassium when starting the diuretic. The team linked these data to zip code-level daily temperature data from the National Oceanic and Atmospheric Administration, and compared two groups—one group included patients who took prescription potassium to prevent hypokalemia when beginning furosemide, and the other included patients who did not take prescription potassium when taking furosemide. The team found that across all temperatures, the potassium-taking group experienced a 9.3 percent lower risk of death than the group who did not take potassium. This survival benefit was also higher when daily maximum temperatures were higher.

“These findings suggest that potassium intake may be important for patients taking furosemide, especially on hot days,” said lead author Young Hee Nam, PhD, a post-doctoral researcher in Biostatistics, Epidemiology and Informatics. “It is also important to understand that our findings do not imply that more potassium is better, and do not imply that prescription potassium may be beneficial for all patients. Further studies are needed to find out the generalizability of our findings to other patient populations. The best way to reduce harmful effects of high temperatures on mortality might be to avoid exposure to high temperatures if possible.”

The latest work follows a 2014 paper in PLOS ONE from the authors which showed that for the many people taking furosemide, mortality rates decline if they also take potassium. The authors emphasized the need for future research into temperature and potassium interaction among different socioeconomic groups, as well as work that considers time spent outside and whether individuals living in warmer regions are better at tolerating increasing temperatures than those who live in cooler climates. Additional Penn authors include Warren B. Bilker and Charles E. Leonard, as well as Michelle L. Bell from Yale University School of Forestry & Environmental Studies. This work was supported by the US National Institute on Aging (R01AG025152) and the US National Institute of Diabetes and Digestive and Kidney Diseases (R01DK102694).

###

Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $7.8 billion enterprise.

The Perelman School of Medicine has been ranked among the top medical schools in the United States for more than 20 years, according to U.S. News & World Report’s survey of research-oriented medical schools. The School is consistently among the nation’s top recipients of funding from the National Institutes of Health, with $405 million awarded in the 2017 fiscal year.

The University of Pennsylvania Health System’s patient care facilities include: The Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center — which are recognized as one of the nation’s top “Honor Roll” hospitals by U.S. News & World Report — Chester County Hospital; Lancaster General Health; Penn Medicine Princeton Health; Penn Wissahickon Hospice; and Pennsylvania Hospital – the nation’s first hospital, founded in 1751. Additional affiliated inpatient care facilities and services throughout the Philadelphia region include Good Shepherd Penn Partners, a partnership between Good Shepherd Rehabilitation Network and Penn Medicine, and Princeton House Behavioral Health, a leading provider of highly skilled and compassionate behavioral healthcare.

Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2017, Penn Medicine provided $500 million to benefit our community.